Andrey A. Kostin

Andrey A. Kostin

Auto-generated profile, based on publicly available information

Andrey A. Kostin

Peoples’ Friendship University of Russia named after Patrice Lumumba

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in RUDN Journal of Medicine
Verified
Journal Article
Open access
PDF file
DADmitrii Atiakshin
Dmitrii Atiakshin
AKAndrey A. Kostin
Andrey A. Kostin
ITIvan D. Trotsenko
Ivan D. Trotsenko
Viktoria ShishkinaViktoria Shishkina
Viktoria Shishkina
MTMarkus Tiemann
Markus Tiemann
ТМТиманн М.
Тиманн М.
Carboxypeptidase A3 (CPA3) is a specific protease of mast cells (MC) with variable expression and appears to be one of the preformed components of the secretome. CPA3 is involved in regulation of the state of a specifi tissue microenvironment and components of the integrative-buffer metabolic environment in adaptive and pathological processes; it affects implementation of the innate immunity, mechanisms of angiogenesis, processes of the extracellular matrix remodeling, etc. CPA3 identification using protocols of multiplex immunohistochemistry allows specifying details of the organ-specific mast cell population features, including the protease phenotype, mechanisms of biogenesis with cytoand histotopographic criteria, and features of secretory pathways. Numerous biological effects of CPA3, including participation in the regulation of the pulmonary parenchyma and systemic blood flow, in biogenesis and remodeling of the fibrous component of the extracellular matrix, in epigenetic reprogramming, determine the importance of fundamental investigation of the physiological activity of protease and its involvement in the implementation of pathological processes. Further studies will contribute to the detection of the translational value of the mast cell CPA3 expression features as a prognostic factor and a promising molecular target for treatment of socially significant diseases.

25 June 2020 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
AKAndrei Kaprin
Andrei Kaprin
EGE. V. Gameeva
E. V. Gameeva
DRD. O. Roshchin
D. O. Roshchin
AKA. A. Kostin
A. A. Kostin
GAG. S. Alekseeva
G. S. Alekseeva
YSYu. V. Samsonov
Yu. V. Samsonov
The article is devoted to the most relevant topic at present — the possibilities of providing full medical care to cancer patients in the context of the spread of the COVID‑19 coronavirus pandemic. Cancer patients are the most vulnerable group, because they are at high risk from the position of immunosuppression, which is often combined with other risk factors for infection: old age, diabetes and cardiovascular diseases. Procrastination and delaying the start of antitumor therapy is unacceptable, since it inevitably leads to a deterioration of treatment results, an increase in one-year mortality and worsens the overall survival rate for malignant neoplasms. Thus, it is necessary to develop a set of measures that will allow all types of anti-cancer treatment to be carried out in parallel with anti-epidemic measures without losing the quality of treatment and preserving the safety of patients and medical personnel.

12 September 2020 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
EGE. V. Gameeva
E. V. Gameeva
AKA. A. Kostin
A. A. Kostin
GAG. S. Alekseeva
G. S. Alekseeva
EOE. U. Ogneva
E. U. Ogneva
PGP. G. Gabay
P. G. Gabay
EKE. V. Kalita
E. V. Kalita
Purpose of the study. To analyze the legal issues, related to the definition of «medical rehabilitation» established in Russian legislation. Materials and methods. A comparative review of the definitions "medical rehabilitation" formulated by World Health Organization and the Russian legislator is made. The main problems of the legal definition of "medical rehabilitation" are studied, including: the problem of distinguishing between "medical rehabilitation" and "treatment". Results. The definition of the term "medical rehabilitation" and terminology used for medical rehabilitation are not consistent in Russian law (legislation still includes such archaic definitions as "rehabilitation treatment" and "rehabilitation medicine"). There is also no unified approach to the question of whether medical rehabilitation is a part of treatment or whether it is an independent stage of medical care. The boundaries between the concepts of "medical rehabilitation" and "treatment" are blurred. Conclusion. The absence of clear boundaries between the definitions of “medical rehabilitation” and “treatment” leads to the risk of violation of licensing requirements by medical organizations, because to determine the list of works (services) to be licensed, it is necessary to correctly determine the specifics of the services provided. The correct classification of a service as medical rehabilitation or medical treatment also effects on the specialization of the involved medical specialists, as well as on the allocated structural units of medical organization. The analysis shows that the main difference between treatment and rehabilitation is the approach. The approach to rehabilitation is broader, it’s primary goal is to return the patient to his previous social status, rather than clinical recovery. At the same time, the main difficulty in distinguishing the mentioned above definitions is related to the fact that the method underlying the medical service is actually licensed, but the same tools and methods can be used both in treatment and medical rehabilitation. Due to these ambiguities, it appears that the current legislation needs to be improved.

1 January 2016 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
ESE. A. Suleimanov
E. A. Suleimanov
EFE. V. Filonenko
E. V. Filonenko
LML. I. Moskvicheva
L. I. Moskvicheva
AKAndrei Kaprin
Andrei Kaprin
AКArray А. Костин
Array А. Костин
AИArray Р. Исаев
Array Р. Исаев
ВОЗМОЖНОСТИ HIFU-ТЕРАПИИ НА СОВРЕМЕННОМ ЭТАПЕ

25 March 2022 in Russian Journal of Telemedicine and E-Health
Verified
Journal Article
Open access
APA.A. Pranovich
A.A. Pranovich
AFA.V. Vishnesky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation
A.V. Vishnesky National Medical Research Center of Surgery of the Ministry of Healthcare of the Russian Federation
AIA.K. Ismailov
A.K. Ismailov
NKN.A. Karelskaya
N.A. Karelskaya
AKA.A. Kostin
A.A. Kostin
RMRussia Moscow
Russia Moscow
Complex health-care data will be growing exponentially as we enter the era of “big data”. Interpretation and analysis of a large amount of medical data for rapid and personalized decision-making require artificial intelligence-driven technologies and data mining techniques. Over the past decade, a rapid transition to the analysis, treatment and monitoring of kidney stone disease using the artificial intelligence (AI) with machine learning algorithms and artificial neural networks ensures the development of precise support systems. Machine learning algorithms able to predict the location of stones using computed tomography scans or ultrasound images, determine their chemical composition, recurrence rate based on demographic and genetic variables, spontaneous ureteral calculous passage, and treatment outcomes. Recent studies use rather simple machine learning methods and small training sets that reduce their accuracy, sensitivity, and specificity and limit their routine application. Therefore, the development of complex architectures, using multilayer artificial neural networks and convolutional neural networks, and integration other heterogeneous variables will improve the resultant predictive accuracy ensuring their introduction in real clinical practice.

29 July 2019 in Experimental and Сlinical Urology
Verified
Journal Article
Closed access
NFN.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation
N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian Federation
LBL.YU. Borisenko
L.YU. Borisenko
ASA.V. Sivkov
A.V. Sivkov
VRV.V. Romikh
V.V. Romikh
AZA.V. Zakharchenko
A.V. Zakharchenko
OAO.I. Apolikhin
O.I. Apolikhin